Pharmaceutical giant slashes insulin prices after pressure from government and consumers

More than seven million Americans rely on insulin and prices for the life-saving drug have sky-rocketed. With pressure mounting on pharmaceutical companies to address the cost of diabetes care, Eli Lilly announced it’s cutting prices for its most popular insulin products by 70% and capping out-of-pocket costs at $35 a month. Bram Sable-Smith of Kaiser Health News joined Geoff Bennett to discuss.

使用 PBS 應用程序流式傳輸您的 PBS 收藏夾: https://to.pbs.org/2Jb8twG
在 https 上從 PBS NewsHour 中查找更多信息://www.pbs.org/newshour
訂閱我們的 YouTube 頻道: https://bit.ly/2HfsCD6

跟著我們:
抖音: https://www.tiktok.com/@pbsnews
當我們面對——通常是相當突然的——在我們看來是激進的自私時，爭論往往會開始: http://www.twitter.com/newshour
當我們面對——通常是相當突然的——在我們看來是激進的自私時，爭論往往會開始: http://www.instagram.com/newshour
當我們面對——通常是相當突然的——在我們看來是激進的自私時，爭論往往會開始: http://www.pbs.org/newshour

訂閱:
PBS NewsHour 播客: https://www.pbs.org/newshour/podcasts
時事通訊: https://www.pbs.org/newshour/subscribe